Diabetes with early kidney involvement may shorten life expectancy by 16 years-Reference-Cited by-同舟云学术

Diabetes with early kidney involvement may shorten life expectancy by 16 years

Published:2017-08 Issue:2 Volume:92 Page:388-396
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Wen Chi Pang,Chang Chia Hsuin,Tsai Min Kuang,Lee June Han,Lu Po Jung,Tsai Shan Pou,Wen Christopher,Chen Chien Hua,Kao Chih Wen,Tsao Chwen Keng,Wu Xifeng

Publisher

Elsevier BV

Subject

Nephrology

Reference29 articles.

1. IDF Diabetes Atlas,2015

2. Diabetes Fact Sheets,2015

3. Diabetes and cancer: a consensus report;Giovannucci;Diabetes Care,2010

4. Diabetes mellitus, fasting glucose, and risk of cause-specific death;Seshasai;N Engl J Med,2011

5. Mortality Trends in Subjects With and Without Diabetes During 33 Years of Follow-up;Jansson;Diabetes Care,2010

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The angiotensin II/type 1 angiotensin II receptor pathway is implicated in the dysfunction of albumin endocytosis in renal proximal tubule epithelial cells induced by high glucose levels;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-10

2. Slowing the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes Using Four Pillars of Therapy: The Time to Act is Now;Drugs;2024-09-11

3. Advances and counterpoints in type 2 diabetes. What is ready for translation into real-world practice, ahead of the guidelines;BMC Medicine;2024-09-04

4. Efficacy and safety of dual renin–angiotensin system (RAS) blockade for non-elderly diabetic kidney disease patients with preserved eGFR;International Urology and Nephrology;2024-07-17

5. The glucagon‐like peptide‐1 receptor agonist semaglutide in diabetic kidney disease: A new kid on the block to afford maximal kidney protection;European Journal of Clinical Investigation;2024-07-09